RxDoctor Payments Data

Emily Agasa, APRN

Family · Houston, TXNPI 1508297086

Payments from drug & device makers

$615in general payments, 2019–2025

Across 23 payments — averaging $26.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$129
  • Theratechnologies Inc.$107
  • Merck$88
  • Pfizer$78
  • Viiv Healthcare Company$58
  • Gilead$46
  • plus $108 from 5 others

What the payments were for

  • Food & beverage$50582%
  • Education$11018%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$615 in reported general payments places this provider in the 60th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$626
Medicare patients
13
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →